Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| R01AI169643 | U.S. NIH Grant/Contract | View source | |
| 20220377 | Other Identifier | University of Miami IRB |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | NIH |
Not provided
Not provided
Not provided
Not provided
This study aims to learn how to help enable healthy behaviors and lower the risk of HIV among Latinx Men.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| I want "Yo Quiero" Control Group | Active Comparator | Participants will receive the standard of care for up to 15-months |
|
| Friend "Amigx" Social network intervention | Experimental | Participant will receive a social network intervention for up to 15-months |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Control group-Standard Health Promotion | Other | Participants will receive the standard of care (beginning of the study) which includes sexual health information once in-person for up to 15 minutes for the duration of the study. |
| Measure | Description | Time Frame |
|---|---|---|
| Number of participants that report using PrEP | PrEP initiation will be measured by analyzing the number of participants that initiate PrEP divided by the total number of participants | Up to 12-months |
| Number of Dried Blood Spot (DBS) tests that report PrEP use | PrEP initiation will be measured by analyzing the number of DBS tests that report PrEP use divided by the total number of participants | Up to 12-months |
| Number of participants that bring a proof of PrEP prescription | PrEP initiation will be measured by analyzing the number of participants that bring proof of a PrEP prescription divided by the total number of participants | Up to 12-months |
| Measure | Description | Time Frame |
|---|---|---|
| PrEP knowledge measured by PrEP knowledge question | Scores range from 1 (I don't know) to 5 (99% or more than 99% effective). Higher scores indicate adequate PrEP knowledge. | Up to 12-months |
| Number of Dried Blood Spot (DBS) tests that report adequate PrEP adherence |
Not provided
Inclusion Criteria
Provision of signed and dated informed consent form
Stated willingness to comply with all study procedures and availability for the duration of the study
Being 18 to 54 years of age
Being a cis-gender male
Self-report one or more of the following behaviors and health conditions in the last 6 months which meet the Centers for Disease Control and Prevention (CDC) clinical guidelines for PrEP eligibility
Self-reported status as HIV negative
Willing to be tested for HIV
Exclusion Criteria
Display diminished capacity to consent because of:
<18 years old or >54 years old
Self-reported living with HIV
Reactive HIV test (for "Amigx" seeds or "Yo Quiero" control participants)
Refusal of HIV test
Identifies as Non-Latinx
Individuals enrolled in other PrEP initiation interventions
Individuals with an active PrEP prescription in the last 6-months (oral or injectable)
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Mariano Kanamori, PhD | Contact | (305) 2430595 | mjk194@miami.edu |
| Name | Affiliation | Role |
|---|---|---|
| Mariano Kanamori, PhD | University of Miami | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Miami | Recruiting | Miami | Florida | 33136 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000163 | Acquired Immunodeficiency Syndrome |
| ID | Term |
|---|---|
| D015658 | HIV Infections |
| D000086982 | Blood-Borne Infections |
| D003141 | Communicable Diseases |
| D007239 | Infections |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Social network intervention | Behavioral | Participants will come to the study location for up to 2 hours three times (beginning of the study, 6-month and 12-month follow-ups) during the duration of the study. During the study, participants will receive sexual health counseling for HIV prevention. Additionally participants will receive information and resources for PrEP usage. Participants will be encouraged to share sexual health information two times (three and nine months after the beginning of the study) during the duration of the study. |
|
PrEP adherence will be measured by analyzing the number of DBS tests that report PrEP adherence divided by the total number of participants that initiate PrEP during the study |
| Up to 12-months |
| D015229 |
| Sexually Transmitted Diseases, Viral |
| D012749 | Sexually Transmitted Diseases |
| D016180 | Lentivirus Infections |
| D012192 | Retroviridae Infections |
| D012327 | RNA Virus Infections |
| D014777 | Virus Diseases |
| D012897 | Slow Virus Diseases |
| D000091662 | Genital Diseases |
| D000091642 | Urogenital Diseases |
| D007153 | Immunologic Deficiency Syndromes |
| D007154 | Immune System Diseases |